Breyer, J., Erben, P., & Worst, T. (2018). High PDL1 mRNA expression predicts better survival of stage pT1 non-muscle-invasive bladder cancer (NMIBC) patients. Cancer immunology immunotherapy, 67(3), . https://doi.org/10.1007/s00262-017-2093-9
Chicago-Zitierstil (17. Ausg.)Breyer, Johannes, Philipp Erben, und Thomas Worst. "High PDL1 MRNA Expression Predicts Better Survival of Stage PT1 Non-muscle-invasive Bladder Cancer (NMIBC) Patients." Cancer Immunology Immunotherapy 67, no. 3 (2018). https://doi.org/10.1007/s00262-017-2093-9.
MLA-Zitierstil (9. Ausg.)Breyer, Johannes, et al. "High PDL1 MRNA Expression Predicts Better Survival of Stage PT1 Non-muscle-invasive Bladder Cancer (NMIBC) Patients." Cancer Immunology Immunotherapy, vol. 67, no. 3, 2018, https://doi.org/10.1007/s00262-017-2093-9.